
01
Developing and diversifying respite structures
02
Consolidating rights and training for carers
03
Improving health monitoring for family carers
04
Quality labelling throughout the country for "single points of contact", the "Maisons pour l’Autonomie et l’Intégration des malades Alzheimer" (MAIA)
05
Establishing "coordinators" throughout the country
06
Reinforcing support at home, advocating services by trained staff
07
Improving support at home using new technologies
08
Preparing and implementing a system for giving the diagnosis and providing counselling
09
Experimenting new payment terms for health professionals
10
Creating an Alzheimer’s disease information card for each patient
11
Creating memory units in areas that are not covered
12
Creating "memory resource and research centres" in areas that are not covered
13
Reinforcing the very active memory units
14
Monitoring drug-related iatrogenic accidents
15
Improving correct use of drugs
16
Creating specific units for patients suffering from behavioural problems within EHPADs
17
Creating specialized units within health care rehabilitation and follow-up (SSR) departments for Alzheimer’s patients
18
Accommodation for young patients
19
Identifying a national reference centre for young Alzheimer’s patients
20
A specific career and skills development plan for Alzheimer’s disease
21
Creating a foundation for scientific cooperation to stimulate and coordinate scientific research
22
Developing clinical research of Alzheimer’s disease and improving evaluation of non-drug therapies
23
Doctoral and post-doctoral grants
24
New assistant surgeon and hospital teaching assistant positions
25
Research in human and social sciences
26
Support for research groups working on innovative approaches
27
Support for methodological research groups in human and social sciences
28
Creation of a body of research in automatic image processing
29
Studying large patient populations (cohorts) with long-term monitoring
30
High-speed genotyping
31
Exploiting the genome sequencing of the microcebe
32
Training in clinical epidemiology
33
Developing links between public research and industry
34
Setting up epidemiological surveillance and follow up
35
Setting up a telephone helpline and a website for information and local advice
36
Holding regional conferences to support the implementation of the plan
37
Studying disease knowledge and attitudes
38
Creating a space for ethical thought about Alzheimer’s disease
39
Launching a discussion about the legal status of Alzheimer’s patients in institutions
40
Organising regular meetings focusing on the autonomy of people suffering from Alzheimer’s disease
41
Informing patients and their families about trials implemented in France
42
Making the fight against Alzheimer’s disease a priority for the European Union during the French presidency
43
Publicizing and promoting research across Europe
44
Holding a European conference in autumn 2008
45
Studying opinion and attitude about Alzheimer’s disease and the impact of the plan among patients and carers
Take more account of the family carer’s health in monitoring Alzheimer’s patients.
One consultation per year for each carer upon request.
Enabling 70% of carers for long-term patients (Affection de longue durée, ALD) to benefit from this consultation.
Including this dimension in the ALD recommendations for Alzheimer’s disease
Identifying this theme in continuing training for doctors
Actions to raise the awareness of carers at the special information point (MAIA - see measure 4)
Lead supervision : Department of Social Security (Direction de la sécurité sociale, DSS) Partners : the National Employees’ Health Insurance Fund (Caisse nationale d’assurance maladie des travailleurs salariés, CNAMTS), the National Health Authority (Haute Autorité de Santé, HAS), doctors’ unions, learned societies, Médéric Alzheimer
Implementation in 2009
Sources of funding: health insurance system
Cost: €5 million per year from 2009, i.e. €20 million over the term of the plan.
Action taken according to the schedule
Research/action comparing the health of carers who have benefited from this follow-up with those who have not.